Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Review

Clinical Trial, Phase III

Multicenter Study

Research Support, Non-U.S. Gov't

Comparative Study

Meta-Analysis

Systematic Review

Clinical Trial, Phase II

Network Meta-Analysis

Clinical Trial Protocol

Equivalence Trial

Comment

Letter

Observational Study

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2019

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Tirzepatide""[mesh_terms]

67 Results

Searching titles within these results

Embracing the Pros and Cons of the New Weight Loss Medications (Semaglutide, Tirzepatide, Etc.).

Mark A Moyad

Current urology reports 2023;24(11):515-525

Full Text

Abstract

Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Maria Cristina Foss-Freitas, Simeon I Taylor, Marissa Lightbourne, Elif A Oral, Rebecca J Brown, David T Broome, Rasimcan Meral, Merve Celik Guler, Diarratou Kaba, Jeevitha Prativadi, Eric D Frontera, Noura Nachawi

Diabetes care 2025;48(5):756-762

Full Text

Abstract

Use of tirzepatide (Mounjaro) in type 2 diabetes management: an overview.

Claire Davies

Nursing standard (Royal College of Nursing (Great Britain) : 1987) 2025;40(7):47-53

Full Text

Abstract

Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era.

Zakariye Isak Mohamed, Abdinasir Adam Shidane, Abdullahi Mohamud Abdiasis, Mohamed Hassan Hussein, Ayaanle Osman Ibrahim, Anas Ali Abdi, Kowthar Ismail Hashi, Mohamed Abdullahi Mohamud, Ali Jimale Mohamed

Endocrinology, diabetes & metabolism 2026;9(5):e70298

Full Text

Abstract

Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study.

Andrea Crafa, Rossella Cannarella, Vincenzo Garofalo, Rosita A Condorelli, Federica Barbagallo, Sandro La Vignera, Aldo E Calogero

Reproductive biology and endocrinology : RB&E 2025;23(1):92

Free Full Text

Abstract

Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials.

Mehmet Kanbay, Sidar Copur, Dimitrie Siriopol, Abdullah Burak Yildiz, Abduzhappar Gaipov, Daniel H van Raalte, Katherine R Tuttle

Diabetes, obesity & metabolism 2023;25(12):3766-3778

Full Text

Abstract

The effects of subcutaneous Tirzepatide on obesity and overweight: a systematic review and meta-regression analysis of randomized controlled trials.

Azita Hekmatdoost, Pejman Rohani, Nasser Malekpour Alamdari, Seyedeh Elaheh Bagheri, Mohammad Hassan Sohouli

Frontiers in endocrinology 2023;14():1230206

Free Full Text

Abstract

Tirzepatide: A New Generation Therapeutic for Diabetes Type 2.

Rami A Al-Horani, Milad Chedid

Endocrine, metabolic & immune disorders drug targets 2023;23(8):1046-1050

Free Full Text

Abstract

Achieving the triple endpoint of body weight reduction thresholds, systolic blood pressure reduction ≥5 mmHg and non-HDL cholesterol <130 mg/dL with tirzepatide in people with obesity: A post hoc analysis from the SURMOUNT trials.

Naveed Sattar, Reshmi Srinath, Luis-Emilio García-Pérez, Clare J Lee, Chrisanthi A Karanikas, Xinyue Chen, Arian Plat

PloS one 2026;21(8):e0345032

Free Full Text

Abstract

Beyond Weight Loss: Skeletal Muscle Health During Incretin-Based Therapy in Patients with Diabesity.

Edoardo Luigi Maria Mollero, Ivan Dozzani, Emilia Biamonte, Giulia Bendotti, Paolo Marzullo, Gianluca Aimaretti, Marco Gallo

Nutrients 2026;18(16):

Full Text

Abstract

Tirzepatide for Weight Loss: Can Medical Therapy "Outweigh" Bariatric Surgery?

William H Frishman, Joel Novograd, Jamie A Mullally

Cardiology in review 2023;31(5):278-283

Full Text

Abstract

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.

Kailei Nong, Qingyang Shi, Xinran Xie, Yang Wang, Arnav Agarwal, Gordon H Guyatt, Haojie Zhang, Yiyuan Gao, Kamlesh Khunti, Carel W Le Roux, Indah S Widyahening, Qinlin Fan, Tianyou Liu, Yunhe Mao, Ivan D Florez, Heyue Du, Xiaohui Pan, Xinyu Zou, Chaoyang Wang, Xiaodong Sun, Jing Li, Qiukui Hao, Qingyi Jia, Feng Sun, Zhiming Zhu, Thomas Agoritsas, Haoming Tian, Per Olav Vandvik, Sheyu Li

BMJ (Clinical research ed.) 2026;394():e372161

Full Text

Abstract

Future directions in obesity pharmacotherapy.

Nick Finer

European journal of internal medicine 2021;93():13-20

Full Text

Abstract

Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials.

Farai Chigutsa, Julia P Dunn, Deborah B Horn, Scott Kahan, Clare J Lee, Rachel L Batterham, Dachuang Cao, Adam Stefanski, Madhumita Murphy, Sylvia Gonsahn-Bollie

Clinical obesity 2025;15(3):e12734

Free Full Text

Abstract

Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists.

Aaron Novikoff, Shannon L O'Brien, Miriam Bernecker, Gerald Grandl, Maximilian Kleinert, Patrick J Knerr, Kerstin Stemmer, Martin Klingenspor, Anja Zeigerer, Richard DiMarchi, Matthias H Tschöp, Brian Finan, Davide Calebiro, Timo D Müller

Molecular metabolism 2022;49():101181

Free Full Text

Abstract

Results: 1 – 15 / 67

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Tirzepatide""[mesh_terms]

Embracing the Pros and Cons of the New Weight Loss Medications (Semaglutide, Tirzepatide, Etc.).

Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Use of tirzepatide (Mounjaro) in type 2 diabetes management: an overview.

Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era.

Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study.

Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials.

The effects of subcutaneous Tirzepatide on obesity and overweight: a systematic review and meta-regression analysis of randomized controlled trials.

Tirzepatide: A New Generation Therapeutic for Diabetes Type 2.

Achieving the triple endpoint of body weight reduction thresholds, systolic blood pressure reduction ≥5 mmHg and non-HDL cholesterol <130 mg/dL with tirzepatide in people with obesity: A post hoc analysis from the SURMOUNT trials.

Beyond Weight Loss: Skeletal Muscle Health During Incretin-Based Therapy in Patients with Diabesity.

Tirzepatide for Weight Loss: Can Medical Therapy "Outweigh" Bariatric Surgery?

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.

Future directions in obesity pharmacotherapy.

Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials.

Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists.

Results for
""Tirzepatide""[mesh_terms]